← Compound index
COMPOUND RECORD / GOTRATIX

GotratixГотратикс

A calf or pig muscle peptide mixture studied alongside regular training in former rowers and track athletes.

Source linked

What the studies found

Comparison in people · 2011

Gotratix With Regular Training: 2011 Grip and Jump Study

Right-hand grip
47 → 53 kgTraining alone: 46 → 47 kgGotratix group before vs after: p < 0.05
Left-hand grip
42 → 48 kgTraining alone: 43 → 45 kgGotratix group before vs after: p < 0.05
Standing long jump
215 → 231 cmTraining alone: 212 → 219 cmGotratix group before vs after: p < 0.05

At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

More reported outcomes
Modified step test
55 → 58 stepsTraining alone: 53 → 57 stepsChange in the Gotratix group was nonsignificant
Flexibility
7.0 → 9.2 cmTraining alone: 6.3 → 7.5 cmChange in the Gotratix group was nonsignificant
Tolerability
The report records no side effects, complications or dependence.The report gives no systematic adverse-event assessment.
Study notes · methods, sources and limitations

Participants or model 37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.

Design Former rowers and track-and-field athletes aged 40–65 continued their regular training. The comparison group trained without Gotratix. Endurance was assessed with a modified Harvard step test, and flexibility with a standing forward bend. Testing sessions were two months apart.

Important limitations

  • The signed scan reports 37 participants (20 Gotratix, 17 controls), but its sex counts sum to 27 and the men’s table repeats the full arm sizes. The compiled editions label the Gotratix arm n=22. The report describes no randomization or blinding and gives no statistical comparison of changes between groups. The institute report has no documented independent peer review. Its short tolerability account cannot establish long-term safety or equivalence to current products. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.
  • The report gives no between-group effect estimate, and the numbers analyzed are unclear. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.

2011 institute report, reproduced by distributors · Institute report — commercial reproduction

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About Gotratix

Identity / background source ↗

Research background

Gotratix is a muscle-derived peptide preparation. A Medical Center report measured grip strength, standing long jump and exercise-test results during a two-month training program.

Compound class
Tissue-derived peptide preparation
Research collection
Peptide bioregulation · editorial grouping
Institutions in linked studies
Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.

Study methods

Small comparative institute report; allocation, blinding and outcome interpretation require caution

Independent replication

Independent replication not established in this collection

Source access

Report reproduction linked; source language and review scope shown per record

Safety evidence

Short-term reports do not establish long-term safety or equivalence to current products

Open a topic for the evidence assessment.

More findings, background and history

What remains unclear

The original report and protocol would clarify group sizes, background treatment and translation. Independent replication and equivalence to current products remain uncertain.

Human reports are linked; their presence does not establish effectiveness. Several publications can describe the same participants.

Browse original study records ↗

Explore the expanded peptide research collection and unresolved source trails ↗

View this preparation in the Khavinson evidence map ↗

03 / SOURCE RECORDS

Findings by study

Tissue-preparation reports: comparisons, source limits and remaining gaps ↗

Explore related research ↗

Comparison in people · 2011

Gotratix With Regular Training: 2011 Grip and Jump Study

At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.

Right-hand grip · 47 → 53 kg · Training alone: 46 → 47 kg · Gotratix group before vs after: p < 0.05

Study notes and original source
2011Human comparative studyRussian-language source

Gotratix With Regular Training: 2011 Grip and Jump Study

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Tissue-derived mixture / named preparation · Institute report — commercial reproduction

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution) · 2011 institute report, reproduced by distributors

At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.

Results and tables

Reported findings and study design

The Gotratix group gained 6 kg in each handgrip test and 16 cm in standing long jump over two months. The report marked all three changes significant from that group’s baseline.

Former rowers and track-and-field athletes aged 40–65 continued their regular training. The comparison group trained without Gotratix. Endurance was assessed with a modified Harvard step test, and flexibility with a standing forward bend. Testing sessions were two months apart.

Population or model 37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.

Dose, route and schedule

The signed Russian report describes two oral 10 mg capsules twice daily with meals for 30 days (40 mg/day). Both groups continued their usual training.

Protocol source ↗ · Russian report, group procedures and capsule strength

Results · 2011 institute report, outcomes table in the Russian scan and Russian and English compilations
MeasureResultComparison, timing and statistics
Right-hand grip47 → 53 kgTraining alone: 46 → 47 kg · Gotratix group before vs after: p < 0.05
Left-hand grip42 → 48 kgTraining alone: 43 → 45 kg · Gotratix group before vs after: p < 0.05
Standing long jump215 → 231 cmTraining alone: 212 → 219 cm · Gotratix group before vs after: p < 0.05
Modified step test55 → 58 stepsTraining alone: 53 → 57 steps · Change in the Gotratix group was nonsignificant
Flexibility7.0 → 9.2 cmTraining alone: 6.3 → 7.5 cm · Change in the Gotratix group was nonsignificant
TolerabilityThe report records no side effects, complications or dependence.The report gives no systematic adverse-event assessment.
2011 exercise-test table
2011 exercise-test table
MeasureGotratix + training, first testGotratix + training, second testTraining alone, first testTraining alone, second test
Right-hand grip (kg)47 ± 2.153 ± 3.9*46 ± 1.447 ± 1.6
Left-hand grip (kg)42 ± 1.748 ± 1.4*43 ± 1.345 ± 1.8
Standing long jump (cm)215 ± 4231 ± 3*212 ± 6219 ± 6
Step test (steps)55 ± 3.158 ± 6.853 ± 6.357 ± 7.5
Flexibility (cm)7.0 ± 1.19.2 ± 2.16.3 ± 2.17.5 ± 1.7

Values are reproduced as M ± m. An asterisk marks p < 0.05 against the first test within the same group. The signed scan labels the table as results in men but lists the full study arm sizes.

The report gives no between-group effect estimate, and the numbers analyzed are unclear. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.

Source for these results ↗ · Reviewed 2026-11-15

Population / setting
37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.
Source reviewed
Methods and numerical table checked against the signed Russian scan and both reprints. The treated-arm count differs by edition.
Study limitations
  • The signed scan reports 37 participants (20 Gotratix, 17 controls), but its sex counts sum to 27 and the men’s table repeats the full arm sizes. The compiled editions label the Gotratix arm n=22.
  • The report describes no randomization or blinding and gives no statistical comparison of changes between groups.
  • The institute report has no documented independent peer review. Its short tolerability account cannot establish long-term safety or equivalence to current products.
  • The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.

Reviewed 2026-11-15.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗